MARIANNE JOHNSTON: Open Payments
NPI 1871724658 · RENTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 21 payments from 10 companies in 2025. Trend: 2023 $1,021 · 2024 $617 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| ABBVIE INC. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Exact Sciences Corporation | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| MIMEDX Group, Inc. | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
Products named: CAPLYTA, QULIPTA, Ozempic, REXULTI, Cologuard Collection Kit, Kerendia, TZIELD, JOURNAVX.
Industry payments across WA — which companies pay providers there.
